Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Anika: Q4 Earnings Snapshot

Anika: Q4 Earnings Snapshot

ANIK : 26.49 (+2.32%)
Anika: Q3 Earnings Snapshot

Anika: Q3 Earnings Snapshot

ANIK : 26.49 (+2.32%)
Anika: Q2 Earnings Snapshot

Anika: Q2 Earnings Snapshot

ANIK : 26.49 (+2.32%)
Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of -97.22% and 2.05%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ANIK : 26.49 (+2.32%)
DNA : 0.8421 (-5.50%)
Anika: Q1 Earnings Snapshot

Anika: Q1 Earnings Snapshot

ANIK : 26.49 (+2.32%)
Anika Therapeutics (ANIK) Stock Sinks As Market Gains: What You Should Know

Anika Therapeutics (ANIK) closed at $26.62 in the latest trading session, marking a -0.89% move from the prior day.

ANIK : 26.49 (+2.32%)
Squarespace, WW International rise; Thor, Anika fall

Stocks that traded heavily or had substantial price changes Tuesday: Squarespace, WW International rise; Thor, Anika fall

QUOT : 3.99 (unch)
CVGI : 5.87 (-2.33%)
OCUL : 5.02 (+5.91%)
DKS : 198.12 (-1.40%)
THO : 98.13 (-1.30%)
ANIK : 26.49 (+2.32%)
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of -54.55% and 3.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ANIK : 26.49 (+2.32%)
AFMD : 5.33 (-0.37%)
Anika: Q4 Earnings Snapshot

Anika: Q4 Earnings Snapshot

ANIK : 26.49 (+2.32%)
Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of -31.25% and 72.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

INO : 11.59 (+1.22%)
ANIK : 26.49 (+2.32%)

Barchart Exclusives

Down 39% YTD, Is It Too Early to Buy the Dip in Intel Stock?
Intel is down 39% this year, and just released disappointing 1Q results. Here is what analysts think of the stock, and whether the worst is over yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar